These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23855817)

  • 21. Future therapeutical strategies dictated by pre-clinical evidence in ALS.
    Fornai F; Meininger V; Silani V
    Arch Ital Biol; 2011 Mar; 149(1):169-74. PubMed ID: 21412723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.
    Goutman SA; Savelieff MG; Sakowski SA; Feldman EL
    Expert Opin Investig Drugs; 2019 Jun; 28(6):525-543. PubMed ID: 31189354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.
    Chen KS; Sakowski SA; Feldman EL
    Ann Neurol; 2016 Mar; 79(3):342-53. PubMed ID: 26696091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotrophic factors and amyotrophic lateral sclerosis.
    Ekestern E
    Neurodegener Dis; 2004; 1(2-3):88-100. PubMed ID: 16908980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenesis and therapeutic perspectives for amyotrophic lateral sclerosis (ALS)].
    Abe K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):790-4. PubMed ID: 18210800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amyotrophic lateral sclerosis--electrophysiologic aspects of its pathophysiology and new therapeutic options].
    Kuwabara S
    Brain Nerve; 2010 Aug; 62(8):885-91. PubMed ID: 20714037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The past, present and future of stem cell clinical trials for ALS.
    Thomsen GM; Gowing G; Svendsen S; Svendsen CN
    Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis.
    Muscaritoli M; Kushta I; Molfino A; Inghilleri M; Sabatelli M; Rossi Fanelli F
    Nutrition; 2012 Oct; 28(10):959-66. PubMed ID: 22677356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
    Mazibuko Z; Choonara YE; Kumar P; Du Toit LC; Modi G; Naidoo D; Pillay V
    J Pharm Sci; 2015 Apr; 104(4):1213-29. PubMed ID: 25559087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis.
    Suzuki M; Svendsen CN
    Trends Neurosci; 2008 Apr; 31(4):192-8. PubMed ID: 18329734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging targets and treatments in amyotrophic lateral sclerosis.
    Zinman L; Cudkowicz M
    Lancet Neurol; 2011 May; 10(5):481-90. PubMed ID: 21511200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
    Papadeas ST; Maragakis NJ
    Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and therapeutic perspectives in amyotrophic lateral sclerosis.
    Mathis S; Couratier P; Julian A; Vallat JM; Corcia P; Le Masson G
    Expert Rev Neurother; 2017 Mar; 17(3):263-276. PubMed ID: 27644548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for amyotrophic lateral sclerosis.
    Federici T; Boulis NM
    Neurobiol Dis; 2012 Nov; 48(2):236-42. PubMed ID: 21889591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amyotrophic lateral sclerosis: update on etiological treatment].
    Ayach L; Curti C; Montana M; Pisano P; Vanelle P
    Therapie; 2013; 68(2):93-106. PubMed ID: 23773350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis.
    Mazzini L; De Marchi F; Buzanska L; Follenzi A; Glover JC; Gelati M; Lombardi I; Maioli M; Mesa-Herrera F; Mitrečić D; Olgasi C; Pivoriūnas A; Sanchez-Pernaute R; Sgromo C; Zychowicz M; Vescovi A; Ferrari D
    Expert Opin Biol Ther; 2024 Sep; 24(9):933-954. PubMed ID: 39162129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyotrophic Lateral Sclerosis: An Update for 2018.
    Oskarsson B; Gendron TF; Staff NP
    Mayo Clin Proc; 2018 Nov; 93(11):1617-1628. PubMed ID: 30401437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward the treatments with neural stem cells: experiences from amyotrophic lateral sclerosis.
    Mitrecić D; Gajović S; Pochet R
    Anat Rec (Hoboken); 2009 Dec; 292(12):1962-7. PubMed ID: 19943351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.